Dasatinib-Induced Rhabdomyolysis in a 33-Year-Old Patient with Chronic Myeloid Leukemia
Rhabdomyolysis is a life-threatening syndrome due to breakdown of the skeletal muscle. It can be caused by massive trauma and crush injuries or occur as a side effect of medications. Here, we describe a case of a 33-year-old male with human immunodeficiency virus (HIV) and newly diagnosed chronic my...
Main Authors: | Andrew Stevenson Joel Chandranesan, Samip Master, Olivia Antosz, Breanne PeytonThomas, Nebu Koshy |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2018/2849869 |
Similar Items
-
Use of dasatinib in chronic myeloid leukemia therapy
by: O. Yu. Vinogradova, et al.
Published: (2008-12-01) -
Dasatinib in chronic myeloid leukemia: a review
by: Dolly G Aguilera, et al.
Published: (2009-03-01) -
An unexpected and devastating adverse event of dasatinib: Rhabdomyolysis
by: Burak Uz, et al.
Published: (2016-01-01) -
The role of dasatinib in the management of chronic myeloid leukemia
by: Chen R, et al.
Published: (2015-02-01) -
Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
by: Radhakrishnan Ramchandren, et al.
Published: (2009-05-01)